We are live on ! Find out more
LA

Linden Advisors Portfolio holdings

AUM $17.9B
1-Year Est. Return 1.72%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+1.72%
3 Year Est. Return
+2.79%
5 Year Est. Return
+3.4%
10 Year Est. Return
+25.58%
AUM
$9.53B
AUM Growth
-$1.41B
Cap. Flow
-$9.67B
Cap. Flow %
-101.51%
Top 10 Hldgs %
31.88%
Holding
730
New
16
Increased
Reduced
3
Closed
155
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VCXB.WS
251
DELISTED
10X Capital Venture Acquisition Corp III Warrants
VCXB.WS
$56.5K ﹤0.01%
749,999
FICVW
252
DELISTED
Frontier Investment Corp Warrants
FICVW
$55.1K ﹤0.01%
333,332
XAGEW
253
DELISTED
Longevity Health Holdings, Inc. Warrant
XAGEW
$55K ﹤0.01%
371,248
CLINW
254
DELISTED
Clean Earth Acquisitions Corp. Warrant
CLINW
$54.4K ﹤0.01%
750,000
CELUW
255
DELISTED
Celularity Inc
CELUW
$53.9K ﹤0.01%
550,119
HOFVW
256
DELISTED
Hall of Fame Resort & Entertainment Company Warrant
HOFVW
$52.6K ﹤0.01%
991,928
HPX.WS
257
DELISTED
HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HPX.WS
$51.9K ﹤0.01%
132,083
BLEUR
258
DELISTED
bleuacacia ltd Rights
BLEUR
$51K ﹤0.01%
600,000
HYMCW
259
DELISTED
Hycroft Mining Holding Corporation Warrant
HYMCW
$51K ﹤0.01%
753,819
VSEEW
260
VSee Health Warrant
VSEEW
$268K
$49.7K ﹤0.01%
500,000
LATGW
261
DELISTED
LatAmGrowth SPAC Warrants
LATGW
$49.2K ﹤0.01%
393,971
ADEX.WS
262
DELISTED
Adit EdTech Acquisition Corp Warrants
ADEX.WS
$43.3K ﹤0.01%
786,403
KYCHR
263
DELISTED
Keyarch Acquisition Corporation Rights
KYCHR
$42.7K ﹤0.01%
510,000
VHAQ.RT
264
DELISTED
Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock
VHAQ.RT
$41.7K ﹤0.01%
370,672
MACAW
265
DELISTED
Moringa Acquisition Corp Warrant
MACAW
$41.5K ﹤0.01%
337,500
NBSTW
266
DELISTED
Newbury Street Acquisition Corporation Warrants
NBSTW
$41.3K ﹤0.01%
553,821
ABPWW
267
DELISTED
Abpro Holdings Warrant
ABPWW
$40.8K ﹤0.01%
499,999
AIIOW
268
Robo.ai Inc Warrant
AIIOW
$482K
$40K ﹤0.01%
+146,975
New +$44.1K
JGGCR
269
DELISTED
Jaguar Global Growth Corporation I Right
JGGCR
$40K ﹤0.01%
500,000
LIVBW
270
DELISTED
LIV Capital Acquisition Corp. II Warrants
LIVBW
$39.5K ﹤0.01%
509,999
ZPTAW
271
DELISTED
Zapata Computing Holdings Inc. Warrant
ZPTAW
$38.5K ﹤0.01%
549,999
PMGMW
272
DELISTED
Priveterra Acquisition Corp. II Warrant to purchase Class A common stock
PMGMW
$38.4K ﹤0.01%
234,376
PLAOW
273
DELISTED
Patria Latin American Opportunity Acquisition Corp. Warrant
PLAOW
$37.5K ﹤0.01%
500,000
JWSM.WS
274
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$37.2K ﹤0.01%
500,000
CDROW icon
275
Codere Online Luxembourg Warrants
CDROW
$5.77M
$37.1K ﹤0.01%
161,123

Similar funds

Linden Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Linden Advisors held 730 positions worth $9.53B, down 13% from $10.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Linden Advisors withdrew a net $9.67B in Q4 2022, closing 155 positions and reducing 3 holdings. Its most notable exit was Angel Pond Holdings Corporation, an estimated $24M position sold in full.

By sector, the portfolio is most concentrated in Financials at 7.8% of assets, down from 10% a quarter earlier, followed by Technology and Industrials.

Against the trend, Linden Advisors opened a new position in Axon Enterprise worth $16M.

  • Linden Advisors's largest Q4 2022 buy was Axon Enterprise: 96,539 shares worth $16M.
  • Linden Advisors's biggest Q4 2022 reduction was Everest Consolidator Acquisition Corporation, cutting an estimated $3.79M.
  • Linden Advisors fully exited Angel Pond Holdings Corporation in Q4 2022, selling an estimated $24M.
  • Linden Advisors's ten largest holdings make up 32% of its $9.53B portfolio in Q4 2022.
  • Linden Advisors opened 16 new positions and closed 155 in Q4 2022.
  • Linden Advisors's portfolio value fell 13% quarter-over-quarter to $9.53B.

Based on Linden Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.